INDICATIONS: Indicated for primary implantation for the visual correction of aphakia in adult patients in whom the cataractous lens has been removed. The lens is intended for placement in the capsular bag.
WARNINGS: Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk / benefit ratio before implanting a lens in a patient. PRECAUTIONS: Do not
resterilize this intraocular lens by any method. Do not store lenses at temperatures over 43°C (110°F). Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide
the benefit/risk ratio before implanting a lens in a patient with conditions as outlined in the enVista IOL Directions for Use. ADVERSE EVENTS: As with any surgical procedure, there is risk involved. Potential
complications accompanying cataract or implant surgery may include, but are not limited to the following: corneal endothelial damage, infection (endophthalmitis), retinal detachment, vitritis, cystoid macular
edema, corneal edema, pupillary block, cyclitic membrane, iris prolapse, hypopyon transient or persistent glaucoma, and secondary surgical intervention. CAUTION: Federal law restricts this device to sale
by or on the order of a physician. ATTENTION: Reference the Directions for Use labeling for a complete listing of indications and important safety information.
®/
™
are trademarks of Bausch & Lomb Incorporated or its affiliates.
© 2017 Bausch & Lomb Incorporated.
EVA.0035.USA.17
The design is distinctive. The outcomes are clear.
Aberration-free optic | Glistening-free performance | Predictable outcomes
Let's be clear about enVista.
enVistaIOL.com • 800.338.2020
